Published in Bioorg Med Chem on August 01, 2001
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol (2013) 5.74
Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon. Br J Pharmacol (2008) 1.54
Prostanoid receptor antagonists: development strategies and therapeutic applications. Br J Pharmacol (2009) 1.31
Suzuki-Miyaura cross-coupling reactions of benzyl halides with potassium aryltrifluoroborates. J Org Chem (2006) 1.27
Cross-couplings between benzylic and aryl halides "on water": synthesis of diarylmethanes. Chem Commun (Camb) (2009) 1.03
Regioselective synthesis of 2-(bromomethyl)-5-aryl-thiophene derivatives via palladium (0) catalyzed suzuki cross-coupling reactions: as antithrombotic and haemolytically active molecules. Chem Cent J (2014) 0.99
Prostaglandin E2 regulates melanocyte dendrite formation through activation of PKCzeta. Exp Cell Res (2007) 0.88
E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype. Br J Pharmacol (2004) 0.87
Endoperoxide 4 receptors play a role in evoking the exercise pressor reflex in rats with simulated peripheral artery disease. J Physiol (2013) 0.87
Dual modulation of urinary bladder activity and urine flow by prostanoid EP3 receptors in the conscious rat. Br J Pharmacol (2009) 0.85
Protection of protease-activated receptor 2 mediated vasodilatation against angiotensin II-induced vascular dysfunction in mice. BMC Pharmacol (2011) 0.82
Prostaglandins of the E series inhibit monoamine release via EP3 receptors: proof with the competitive EP3 receptor antagonist L-826,266. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.79
Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists. ACS Med Chem Lett (2010) 0.78
Fluorescent Human EP3 Receptor Antagonists. ACS Med Chem Lett (2012) 0.77
Obligatory Role of EP1 Receptors in the Increase in Cerebral Blood Flow Produced by Hypercapnia in the Mice. PLoS One (2016) 0.77
Periaqueductal Grey EP3 Receptors Facilitate Spinal Nociception in Arthritic Secondary Hypersensitivity. J Neurosci (2016) 0.75
Adenosine A(1) and prostaglandin E receptor 3 receptors mediate global airway contraction after local epithelial injury. Am J Respir Cell Mol Biol (2012) 0.75
Analgesic and anti-inflammatory properties of novel, selective, and potent EP4 receptor antagonists. Pharmacol Res Perspect (2017) 0.75
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (1995) 15.07
Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature (1999) 3.57
Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem (2000) 2.89
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta (2000) 2.37
Extension of cell life-span and telomere length in animals cloned from senescent somatic cells. Science (2000) 2.25
The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat Struct Biol (1996) 2.17
L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol (1989) 1.88
Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide. Proc Natl Acad Sci U S A (2001) 1.68
Molecular cloning and characterization of the human prostanoid DP receptor. J Biol Chem (1995) 1.61
Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. J Biol Chem (1993) 1.59
An assay to determine the kinetics of RNA cleavage. Anal Biochem (1985) 1.57
Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur J Pharmacol (1997) 1.56
Acute biochemical variations induced by four different calcium salts in healthy male volunteers. Osteoporos Int (1993) 1.46
Outcome of rationing access to open-heart surgery: effect of the wait for elective surgery on patient outcome. CMAJ (1993) 1.43
Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol (1995) 1.41
Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2). Mol Pharmacol (2001) 1.35
Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. Br J Pharmacol (1999) 1.34
Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J Allergy Clin Immunol (2001) 1.32
Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex. Mol Pharmacol (1989) 1.28
Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype. J Biol Chem (1994) 1.28
Cloning and expression of a cDNA for the human prostanoid FP receptor. J Biol Chem (1994) 1.25
1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet (1987) 1.21
The DnaJ domain of polyomavirus large T antigen is required to regulate Rb family tumor suppressor function. J Virol (1997) 1.21
Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol Pharmacol (1995) 1.18
Purification of the simian virus 40 (SV40) T antigen DNA-binding domain and characterization of its interactions with the SV40 origin. J Virol (1997) 1.15
Sinks for nitrogen inputs in terrestrial ecosystems: a meta-analysis of 15N tracer field studies. Ecology (2012) 1.12
Isolation of endothelial cells from brain, lung, and kidney: expression of the multidrug resistance P-glycoprotein isoforms. Biochem Biophys Res Commun (2001) 1.11
Cloning and expression of a cDNA for the human prostanoid IP receptor. J Biol Chem (1994) 1.09
Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist. Br J Pharmacol (1998) 1.08
Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol (1992) 1.08
Hemodynamic and pharmacodynamic comparison of doxacurium and high-dose vecuronium during coronary artery bypass surgery: a cost-benefit study. J Cardiothorac Vasc Anesth (1994) 1.06
Prevention of postmenopausal bone loss by tiludronate. Lancet (1990) 1.05
Brain endo-oligopeptidase A, a putative enkephalin converting enzyme. J Neurochem (1987) 1.04
L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist. Can J Physiol Pharmacol (1986) 1.04
Cellular distribution of prostanoid EP receptors mRNA in the rat gastrointestinal tract. Prostaglandins Other Lipid Mediat (2000) 1.04
Accidental caustic ingestion in children: is endoscopy always mandatory? J Pediatr Gastroenterol Nutr (2001) 1.00
Community health effects of a municipal water supply hyperfluoridation accident. Am J Public Health (1988) 0.97
Comment on 'Vitreomacular traction syndrome: a comparison of treatment with intravitreal plasmin enzyme vs spontaneous vitreous separation without treatment'. Eye (Lond) (2013) 0.97
A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor. Eur J Pharmacol (1999) 0.96
Key structural features of prostaglandin E(2) and prostanoid analogs involved in binding and activation of the human EP(1) prostanoid receptor. Mol Pharmacol (2001) 0.96
Cloning and expression of three isoforms of the human EP3 prostanoid receptor. FEBS Lett (1994) 0.96
The effects of acetylcholine on response properties of cat somatosensory cortical neurons. J Neurophysiol (1988) 0.94
Purification of human leukotriene C4 synthase from dimethylsulfoxide-differentiated U937 cells. Eur J Biochem (1992) 0.93
Biological and molecular characteristics of an HEV isolate associated with recent acute outbreaks of encephalomyelitis in Quebec pig farms. Adv Exp Med Biol (2001) 0.93
Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly. FEBS Lett (1999) 0.92
Binding of [3H]cimetidine to rat brain tissue. Agents Actions (1980) 0.92
Pharmacological study of the effects of leukotrienes C4, D4, E4 & F4 on guinea pig trachealis: interaction with FPL-55712. Prostaglandins (1983) 0.92
Phylogeography of mitochondrial DNA variation in brown bears and polar bears. Mol Phylogenet Evol (2000) 0.92
Investigation of the mechanism of non-turnover-dependent inactivation of purified human 5-lipoxygenase. Inactivation by H2O2 and inhibition by metal ions. Eur J Biochem (1992) 0.92
Mapping initiation sites for simian virus 40 DNA synthesis events in vitro. Mol Cell Biol (1994) 0.92
Chromogranin A can act as a reversible processing enzyme inhibitor. Evidence from the inhibition of the IRCM-serine protease 1 cleavage of pro-enkephalin and ACTH at pairs of basic amino acids. FEBS Lett (1987) 0.92
Enkephalin is liberated from metorphamide and dynorphin A1-8 by endo-oligopeptidase A, but not by metalloendopeptidase EC 3.4.24.15. Biochem J (1988) 0.91
Comparative water use by the riparian trees Melaleuca argentea and Corymbia bella in the wet-dry tropics of northern Australia. Tree Physiol (2006) 0.90
Identification and characterization of a novel HIV-1 nucleotide-competing reverse transcriptase inhibitor series. Antimicrob Agents Chemother (2013) 0.90
Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin. J Bone Miner Res (1994) 0.90
Transient and prolonged effects of acetylcholine on responsiveness of cat somatosensory cortical neurons. J Neurophysiol (1988) 0.89
Role of phospholipase A(2) on the variations of the choline signal intensity observed by 1H magnetic resonance spectroscopy in brain diseases. Brain Res Brain Res Rev (2000) 0.89
Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey. Brain Res (2001) 0.89
Skin equivalent produced with human collagen. In Vitro Cell Dev Biol Anim (1995) 0.89
[Rehabilitation on functional amblyopia in Morning Glory Syndrome]. J Fr Ophtalmol (2007) 0.88
Morphologic and functional properties of bronchial cells isolated from normal and asthmatic subjects. Am J Respir Cell Mol Biol (1996) 0.88
Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe. Anal Biochem (1999) 0.88
Placental anomalies in a viable cloned calf. Cloning (2001) 0.87
Thalamic VPM nucleus in the behaving monkey. I. Multimodal and discriminative properties of thermosensitive neurons. J Neurophysiol (1993) 0.85
Structure-activity relationship of biaryl acylsulfonamide analogues on the human EP(3) prostanoid receptor. Bioorg Med Chem Lett (2002) 0.85
Bilateral osseous choristoma. J Pediatr Ophthalmol Strabismus (2000) 0.85
Opioid peptide precursors in striatum. FEBS Lett (1980) 0.84
The stratification of cardiac surgical procedures according to use of blood products: a retrospective analysis of 1480 cases. Can J Anaesth (1991) 0.83